Scientia Vascular, developer of innovative products that are optimized for endovascular access and therapies, announced today that its PLATOTM Microcath has received CE (Conformité Européenne) Mark approval, facilitating availability for European neuro, cardio and peripheral endovascular applications.

"PLATO Microcath's performance is unique, respective to providing a very stable support and more control of the distal tip. This is ideal for precise coil delivery into an intracranial aneurysm."

Engineered with breakthrough microfabrication technology, PLATO microcatheters provide excellent trackability and distal access. PLATO also offers a stable platform for delivery of therapeutic implants, such as detachable coils and stents.

According to Professor Dr. Boris Lubicz, M.D., Ph.D., Erasme University Hospital, Brussels, Belgium, "PLATO Microcath's performance is unique, respective to providing a very stable support and more control of the distal tip. This is ideal for precise coil delivery into an intracranial aneurysm."

The PLATO microcatheter design features a proximal stainless steel hypotube, with 1:1 push response, and a proprietary microfabricated polymer distal shaft. The hypotube is placed into the guiding catheter, from which the distal shaft exits to be placed into distal anatomy for precise control at the site of therapy. PLATO is available in straight and pre-shaped, one- and two-tip marker configurations to allow access and stability in various anatomical locations and morphologies. Catheter tips may also be steam-shaped for specific physician needs.

Kevin Riley, President & COO of Scientia Vascular, commented, "With an increasing number of neuro endovascular devices to treat hemorrhagic and ischemic stroke available on the European market, the PLATO design should offer increased performance to the neurovascular interventionalist for these procedures."

Note: PLATO microcatheters are not yet available for sale in the United States.

Source:
Scientia Vascular, LLC

Tag Cloud